PCA3 score and prostate cancer diagnosis at repeated saturation biopsy. Which cut-off: 20 or 35?

Contemporary role of prostate cancer gene 3 in the management of prostate cancer

(2011) Monique J Roobol   CURRENT OPINION IN UROLOGY

Urinary PCA3 Score Predicts Prostate Cancer Multifocality

(2011) Virginie Vlaeminck-Guillem et al.   JOURNAL OF UROLOGY

Follow-up of men with an elevated PCA3 score and a negative biopsy: does an elevated PCA3 score indeed predict the presence of prostate cancer?

(2010) Mesut Remzi et al.   BJU INTERNATIONAL

Performance of Prostate Cancer Antigen 3 (PCA3) and Prostate-Specific Antigen in Prescreened Men: Reproducibility and Detection Characteristics for Prostate Cancer Patients with High PCA3 Scores (≥100)

(2010) Monique J. Roobol et al.   EUROPEAN UROLOGY

Critical Assessment of Preoperative Urinary Prostate Cancer Antigen 3 on the Accuracy of Prostate Cancer Staging

(2010) Marco Auprich et al.   EUROPEAN UROLOGY

Prostate Cancer Detection in the “Grey Area” of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun’s Nomogram, Two Risk Estimators Incorporating Prostate Cancer Antigen 3

(2010) Sisto Perdonà et al.   EUROPEAN UROLOGY

Prostate Cancer Antigen 3 Score Accurately Predicts Tumour Volume and Might Help in Selecting Prostate Cancer Patients for Active Surveillance

(2010) Guillaume Ploussard et al.   EUROPEAN UROLOGY

PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial

(2010) Sheila M.J. Aubin et al.   JOURNAL OF UROLOGY

Incidence of insignificant prostate cancer using free/total PSA: results of a case-finding protocol on 14 453 patients

(2010) P Pepe et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Interpretation of the Prostate Cancer Gene 3 in Reference to the Individual Clinical Background: Implications for Daily Practice

(2010) David Schilling et al.   UROLOGIA INTERNATIONALIS

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Urinary Prostate Cancer 3 Test: Toward the Age of Reason?

(2009) Virginie Vlaeminck-Guillem et al.   UROLOGY

Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy

(2008) Alexander Haese et al.   EUROPEAN UROLOGY